{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:41:26Z","timestamp":1791232886259,"version":"4.1.0"},"reference-count":161,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.isci.2026.115441","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T15:57:58Z","timestamp":1775231878000},"page":"115441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence"],"prefix":"10.1016","volume":"29","author":[{"given":"Be\u00e1ta-M\u00e1ria","family":"Benk\u0151","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neuza Sofia","family":"De Brito Parreirinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Sebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5419-9137","authenticated-orcid":false,"given":"Rom\u00e1na","family":"Zelk\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115441_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JRS-170737","article-title":"Off-label use of medicines: The need for good practice guidelines","volume":"29","author":"Dooms","year":"2017","journal-title":"Int. J. Risk Saf. Med."},{"key":"10.1016\/j.isci.2026.115441_bib2","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.clinthera.2018.07.012","article-title":"Pharmacovigilance: An overview","volume":"40","author":"Beninger","year":"2018","journal-title":"Clin. Ther."},{"key":"10.1016\/j.isci.2026.115441_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jacbts.2022.12.011","article-title":"Off-label use vs off-label marketing of drugs: Part 1: Off-label use-patient harms and prescriber responsibilities","volume":"8","author":"Van Norman","year":"2023","journal-title":"JACC, Basic Transl. Sci."},{"key":"10.1016\/j.isci.2026.115441_bib4","unstructured":"EUPATI Open Classroom, Off-label use. https:\/\/learning.eupati.eu\/mod\/book\/view.php?id=913&chapterid=896."},{"key":"10.1016\/j.isci.2026.115441_bib5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.drudis.2015.11.009","article-title":"Extensions of indication throughout the drug product lifecycle: a quantitative analysis","volume":"21","author":"Langedijk","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2026.115441_bib6","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/jphp.13273","article-title":"Drug repositioning: a brief overview","volume":"72","author":"Jourdan","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.isci.2026.115441_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.115441_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11030-025-11248-w","article-title":"Recent advances in drug repositioning and rediscovery for different therapeutic activities utilizing updated technological approaches","volume":"30","author":"Nossier","year":"2026","journal-title":"Mol. Divers."},{"key":"10.1016\/j.isci.2026.115441_bib9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/antibiotics12030524","article-title":"Disulfiram: Mechanisms, applications, and challenges","volume":"12","author":"Lanz","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.isci.2026.115441_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121335","article-title":"Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens","volume":"281","author":"Lu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.isci.2026.115441_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13643-021-01858-4","article-title":"Anticancer effects of disulfiram: a systematic review of in vitro, animal, and human studies","volume":"11","author":"Wang","year":"2022","journal-title":"Syst. Rev."},{"key":"10.1016\/j.isci.2026.115441_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0971-8990.164826","article-title":"Tracing the journey of disulfiram: From an unintended discovery to a treatment option for alcoholism","volume":"20","author":"Pattanayak","year":"2015","journal-title":"J. Ment. Health Hum. Behav."},{"key":"10.1016\/j.isci.2026.115441_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The Drug Repurposing Hub: a next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.115441_bib14","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2014 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115441_bib15","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3390\/v17070881","article-title":"COVID-19 and a tale of three drugs: To repurpose, or not to repurpose-that was the question","volume":"17","author":"Triggle","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.isci.2026.115441_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00280-020-04216-8","article-title":"Disulfiram: a novel repurposed drug for cancer therapy","volume":"87","author":"Lu","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.isci.2026.115441_bib17","article-title":"Disulfiram: A repurposed drug in preclinical and clinical development for the treatment of infectious diseases","volume":"20","author":"Custodio","year":"2022","journal-title":"Antiinfect. Agents"},{"key":"10.1016\/j.isci.2026.115441_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1498204","article-title":"Safety assessment of disulfiram: real-world adverse event analysis based on FAERS database","volume":"15","author":"Luo","year":"2024","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.isci.2026.115441_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11060-016-2104-2","article-title":"A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy","volume":"128","author":"Huang","year":"2016","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.isci.2026.115441_bib20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2024.05.009","article-title":"A phase 1\/2 study of disulfiram and copper with concurrent radiation therapy and temozolomide for patients with newly diagnosed glioblastoma","volume":"120","author":"Huang","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.isci.2026.115441_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11060-018-2775-y","article-title":"Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma","volume":"138","author":"Huang","year":"2018","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.isci.2026.115441_bib22","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/ph14121241","article-title":"In vitro and clinical compassionate use experiences with the drug-repurposing approach CUSP9v3 in glioblastoma","volume":"14","author":"Halatsch","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.isci.2026.115441_bib23","first-page":"vdab075","article-title":"A phase Ib\/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3. Neurooncol","volume":"3","author":"Halatsch","year":"2021","journal-title":"Adv"},{"key":"10.1016\/j.isci.2026.115441_bib24","first-page":"1227","article-title":"Evidence for the efficacy of disulfiram and copper combination in glioblastoma multiforme - A propos of a case","volume":"22","author":"Karamanakos","year":"2017","journal-title":"J. Buon."},{"key":"10.1016\/j.isci.2026.115441_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.psym.2019.09.003","article-title":"Posterior reversible encephalopathy syndrome instigated by off-label disulfiram use for metastatic melanoma","volume":"61","author":"Beam","year":"2020","journal-title":"Psychosomatics"},{"key":"10.1016\/j.isci.2026.115441_bib26","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature25016","article-title":"Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4","volume":"552","author":"Skrott","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115441_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fmed.2020.00133","article-title":"Potential patient-reported toxicities with disulfiram treatment in late disseminated Lyme disease","volume":"7","author":"Trautmann","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.isci.2026.115441_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/antibiotics8020072","article-title":"Disulfiram (tetraethylthiuram disulfide) in the treatment of Lyme disease and babesiosis: Report of experience in three cases","volume":"8","author":"Liegner","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.isci.2026.115441_bib29","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/antibiotics9120868","article-title":"\u201cRepurposing\u201d disulfiram in the treatment of Lyme disease and babesiosis: Retrospective review of first 3 years\u2019 experience in one medical practice","volume":"9","author":"Gao","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.isci.2026.115441_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1549324","article-title":"A pilot study of disulfiram for individuals with persistent symptoms despite prior antibiotic treatment for Lyme disease","volume":"12","author":"Kuvaldina","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.isci.2026.115441_bib31","series-title":"Recovery from Lyme Disease: The Integrative Medicine Guide to Diagnosing and Treating Tick-Borne Illness","author":"Kinderlehrer","year":"2021"},{"key":"10.1016\/j.isci.2026.115441_bib32","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1016\/S2352-3018(15)00226-X","article-title":"Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study","volume":"2","author":"Elliott","year":"2015","journal-title":"Lancet HIV"},{"key":"10.1016\/j.isci.2026.115441_bib33","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1038\/s41467-022-34671-1","article-title":"Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism","volume":"13","author":"Lei","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115441_bib34","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41598-018-19577-7","article-title":"Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer's disease hallmarks","volume":"8","author":"Reinhardt","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115441_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047702","article-title":"The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial","volume":"7","author":"Haile","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.115441_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.biopsych.2012.07.011","article-title":"Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine \u03b2-hydroxylase","volume":"73","author":"Kosten","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.isci.2026.115441_bib37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugalcdep.2013.12.007","article-title":"Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment","volume":"136","author":"Schottenfeld","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.isci.2026.115441_bib38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/15563650.2017.1355057","article-title":"Acute pneumonitis associated with nickel carbonyl exposure in the workplace","volume":"56","author":"Bowman","year":"2018","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.isci.2026.115441_bib39","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.2147\/IJN.S137347","article-title":"Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent","volume":"12","author":"Wehbe","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.isci.2026.115441_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.actbio.2017.12.023","article-title":"Repurposing disulfiram for cancer therapy via targeted nanotechnology through enhanced tumor mass penetration and disassembly","volume":"68","author":"He","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.isci.2026.115441_bib41","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1021\/acs.molpharmaceut.0c00284","article-title":"Nanoscale copper(II)-diethyldithiocarbamate coordination polymer as a drug self-delivery system for highly robust and specific cancer therapy","volume":"17","author":"Peng","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.isci.2026.115441_bib42","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.7150\/thno.45558","article-title":"Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting","volume":"10","author":"Ren","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.115441_bib43","doi-asserted-by":"crossref","first-page":"12156","DOI":"10.1002\/chem.202101366","article-title":"Inclusion complexes of gold(I)-dithiocarbamates with \u03b2-cyclodextrin: a journey from drug repurposing towards drug discovery","volume":"27","author":"Morgen","year":"2021","journal-title":"Chemistry"},{"key":"10.1016\/j.isci.2026.115441_bib44","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jconrel.2020.10.052","article-title":"Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity","volume":"329","author":"Zhao","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.115441_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/app.53043","article-title":"Self-assembled nanoprodrugs from reducible dextran-diethyldithiocarbamate conjugates for robust tumor-targeted chemotherapy","volume":"139","author":"Jin","year":"2022","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.isci.2026.115441_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121788","article-title":"Sphingomyelin-based PEGylation Cu(DDC)2 liposomes prepared via the dual function of Cu2+ for cancer therapy: facilitating DDC loading and exerting synergistic antitumor effects","volume":"621","author":"Liu","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2026.115441_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113253","article-title":"DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11\/GPX4-mediated ferroptosis","volume":"225","author":"Li","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.isci.2026.115441_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.146277","article-title":"Biomineralized nanomedicine for enhanced cancer therapy through in situ toxification and amplified Ca2+ overload","volume":"475","author":"Peng","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.isci.2026.115441_bib49","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1248\/bpb.b23-00789","article-title":"Development of hollow gold nanoparticles for photothermal therapy and their cytotoxic effect on a glioma cell line when combined with copper diethyldithiocarbamate","volume":"47","author":"Liu","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.isci.2026.115441_bib50","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.apsb.2024.03.003","article-title":"Repurposing disulfiram with CuET nanocrystals: Enhancing anti-pyroptotic effect through NLRP3 inflammasome inhibition for treating inflammatory bowel diseases","volume":"14","author":"Xu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.isci.2026.115441_bib51","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1021\/acsbiomaterials.5c00680","article-title":"DDTC-Cu(I) nano-MOF induces ferroptosis by targeting SLC7A11\/GPX4 signal in colorectal cancer","volume":"11","author":"Huang","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.isci.2026.115441_bib52","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1248\/bpb.b24-00538","article-title":"Anticancer effects of new disulfiram analogs","volume":"47","author":"Abdullah","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.isci.2026.115441_bib53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/17425247.2023.2190581","article-title":"Clinical, pharmacological, and formulation evaluation of disulfiram in the treatment of glioblastoma - a systematic literature review","volume":"20","author":"Benk\u0151","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.isci.2026.115441_bib54","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1039\/c5tx00210a","article-title":"The cytotoxic mechanisms of disulfiram and copper(II) in cancer cells","volume":"4","author":"Tawari","year":"2015","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.isci.2026.115441_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.120732","article-title":"Evaluation of the accumulation of disulfiram and its copper complex in A549 cells using mass spectrometry","volume":"211","author":"Lu","year":"2020","journal-title":"Talanta"},{"key":"10.1016\/j.isci.2026.115441_bib56","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1124\/dmd.120.000317","article-title":"Dual action of acidic microenvironment on the enrichment of the active metabolite of disulfiram in tumor tissues","volume":"49","author":"Tang","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.isci.2026.115441_bib57","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/1878-0261.13114","article-title":"Cannabidiol-induced activation of the metallothionein pathway impedes anticancer effects of disulfiram and its metabolite CuET","volume":"16","author":"Buchtova","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.isci.2026.115441_bib58","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2174\/0115680096325879240815105227","article-title":"Disulfiram-copper potentiates anticancer efficacy of standard chemotherapy drugs in bladder cancer animal model through ROS-autophagy-ferroptosis signalling cascade","volume":"25","author":"Sharma","year":"2025","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.isci.2026.115441_bib59","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1158\/1078-0432.CCR-15-1798","article-title":"Disulfiram when combined with copper enhances the therapeutic effects of temozolomide for the treatment of glioblastoma","volume":"22","author":"Lun","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.115441_bib60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1515\/ejnm-2017-0013","article-title":"Disulfiram and disulfiram-loaded poly-[lactide-co-glycolic acid] nanoparticles modulate metastatic markers and proteasomal activity in hepatocarcinoma Hep3b cell line","volume":"9","author":"Hoda","year":"2017","journal-title":"Eur. J. Nanomed."},{"key":"10.1016\/j.isci.2026.115441_bib61","doi-asserted-by":"crossref","first-page":"25848","DOI":"10.18632\/oncotarget.15667","article-title":"Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: Use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies","volume":"8","author":"Arora","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.115441_bib62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2017.08.028","article-title":"A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram","volume":"409","author":"Cong","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.115441_bib63","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/neuonc\/now300","article-title":"Repositioning disulfiram as a radiosensitizer against atypical teratoid\/rhabdoid tumor","volume":"19","author":"Lee","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.isci.2026.115441_bib64","article-title":"The anti-alcohol dependency drug disulfiram inhibits the viability and progression of gastric cancer cells by regulating the Wnt and NF-\u03baB pathways","volume":"48","author":"Zhang","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.isci.2026.115441_bib65","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jb\/mvab045","article-title":"The disulfiram\/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS\/JNK signalling pathway","volume":"170","author":"Guo","year":"2021","journal-title":"J. Biochem."},{"key":"10.1016\/j.isci.2026.115441_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110048","article-title":"Disulfiram\/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways","volume":"126","author":"Xu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.isci.2026.115441_bib67","doi-asserted-by":"crossref","first-page":"82200","DOI":"10.18632\/oncotarget.9413","article-title":"Effective elimination of adult B-lineage acute lymphoblastic leukemia by disulfiram\/copper complex in vitro and in vivo in patient-derived xenograft models","volume":"7","author":"Deng","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.115441_bib68","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1248\/bpb.b21-00353","article-title":"Disulfiram synergizes with SRC inhibitors to suppress the growth of pancreatic ductal adenocarcinoma cells in vitro and in vivo","volume":"44","author":"Li","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.isci.2026.115441_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174107","article-title":"Disulfiram\/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy","volume":"902","author":"Zha","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.isci.2026.115441_bib70","first-page":"1266","article-title":"Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: An uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram","volume":"9","author":"Zhang","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.isci.2026.115441_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2021.119087","article-title":"Anti-proliferative activity of disulfiram through regulation of the AKT-FOXO axis: A proteomic study of molecular targets","volume":"1868","author":"Nasrollahzadeh","year":"2021","journal-title":"Biochim. Biophys. Acta. Mol. Cell Res."},{"key":"10.1016\/j.isci.2026.115441_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102122","article-title":"Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram\/copper-induced ferroptosis","volume":"46","author":"Ren","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2026.115441_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167455","article-title":"Disulfiram\/copper complex improves the effectiveness of the WEE1 inhibitor Adavosertib in p53 deficient non-small cell lung cancer via ferroptosis","volume":"1870","author":"Liu","year":"2024","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"key":"10.1016\/j.isci.2026.115441_bib74","doi-asserted-by":"crossref","first-page":"333","DOI":"10.32604\/or.2023.028694","article-title":"Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways","volume":"31","author":"Gan","year":"2023","journal-title":"Oncol. Res."},{"key":"10.1016\/j.isci.2026.115441_bib75","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2024.06.006","article-title":"GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF\/Cu-induced cuproptosis in myelodysplastic syndromes","volume":"222","author":"Li","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.isci.2026.115441_bib76","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/odi.13652","article-title":"Repurposing disulfiram to induce OSCC cell death by cristae dysfunction promoted autophagy","volume":"27","author":"Wang","year":"2021","journal-title":"Oral Dis."},{"key":"10.1016\/j.isci.2026.115441_bib77","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.7150\/ijbs.105575","article-title":"Disulfiram\/copper triggers cGAS-STING innate immunity pathway via ROS-induced DNA damage that potentiates antitumor response to PD-1 checkpoint blockade","volume":"21","author":"Yuan","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.isci.2026.115441_bib78","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12964-019-0507-3","article-title":"Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram","volume":"18","author":"Sun","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.isci.2026.115441_bib79","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.6015","article-title":"Identification of tumour-infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma","volume":"259","author":"Lu","year":"2023","journal-title":"J. Pathol."},{"key":"10.1016\/j.isci.2026.115441_bib80","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7157507","article-title":"ALDH1A1 gene expression and cellular copper levels between low and highly metastatic osteosarcoma provide a case for novel repurposing with disulfiram and copper","volume":"2022","author":"Mandell","year":"2022","journal-title":"Sarcoma"},{"key":"10.1016\/j.isci.2026.115441_bib81","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1038\/s41388-019-0915-2","article-title":"Disulfiram's anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase","volume":"38","author":"Skrott","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.115441_bib82","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3390\/biom11111561","article-title":"Repurposing disulfiram for targeting of glioblastoma stem cells: An in vitro study","volume":"11","author":"Zirjacks","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.isci.2026.115441_bib83","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/cells9020469","article-title":"Targeting the NPL4 adaptor of p97\/VCP segregase by disulfiram as an emerging cancer vulnerability evokes replication stress and DNA damage while silencing the ATR pathway","volume":"9","author":"Majera","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.115441_bib84","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/s41418-023-01167-4","article-title":"Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET","volume":"30","author":"Kanellis","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.isci.2026.115441_bib85","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1038\/s41598-019-41187-0","article-title":"Anti-alcohol abuse drug disulfiram inhibits human PHGDH via disruption of its active tetrameric form through a specific cysteine oxidation","volume":"9","author":"Spillier","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115441_bib86","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.3390\/molecules24183409","article-title":"Drug repurposing as an antitumor agent: disulfiram-mediated carbonic anhydrase 12 and anion exchanger 2 modulation to inhibit cancer cell migration","volume":"24","author":"Hwang","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2026.115441_bib87","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41419-021-04078-9","article-title":"Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation","volume":"12","author":"Meier","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.115441_bib88","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022110636","article-title":"Disulfiram bolsters T-cell anti-tumor immunity through direct activation of LCK-mediated TCR signaling","volume":"41","author":"Wang","year":"2022","journal-title":"EMBO J."},{"key":"10.1016\/j.isci.2026.115441_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43219-2","article-title":"Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water\/oil emulsion","volume":"13","author":"Beaudry","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115441_bib90","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/biom14101295","article-title":"Selective inhibition of deamidated triosephosphate isomerase by disulfiram, curcumin, and sodium dichloroacetate: synergistic therapeutic strategies for T-cell acute lymphoblastic leukemia in Jurkat cells","volume":"14","author":"Flores-L\u00f3pez","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.isci.2026.115441_bib91","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijbiomac.2021.02.072","article-title":"Disulfiram and 6-Thioguanine synergistically inhibit the enzymatic activities of USP2 and USP21","volume":"176","author":"Lin","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.isci.2026.115441_bib92","doi-asserted-by":"crossref","first-page":"F7","DOI":"10.1097\/QAD.0b013e3283570620","article-title":"Disulfiram reactivates latent HIV-1 expression through depletion of the phosphatase and tensin homolog","volume":"27","author":"Doyon","year":"2013","journal-title":"Aids"},{"key":"10.1016\/j.isci.2026.115441_bib93","doi-asserted-by":"crossref","first-page":"27381","DOI":"10.1073\/pnas.2010470117","article-title":"Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs","volume":"117","author":"Li","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.115441_bib94","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1021\/acsinfecdis.1c00017","article-title":"Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2","volume":"7","author":"Biering","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.isci.2026.115441_bib95","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.apsb.2020.08.014","article-title":"Crystal structure of SARS-CoV-2 papain-like protease","volume":"11","author":"Gao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.isci.2026.115441_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.952192","article-title":"Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19","volume":"13","author":"Alegr\u00eda-Arcos","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2026.115441_bib97","first-page":"3333","article-title":"Disulfiram blocked cell entry of SARS-CoV-2 via inhibiting the interaction of spike protein and ACE2","volume":"12","author":"Chen","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.isci.2026.115441_bib98","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.apsb.2021.10.026","article-title":"Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays","volume":"12","author":"Ma","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.isci.2026.115441_bib99","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00044-022-02903-0","article-title":"Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor","volume":"31","author":"Tan","year":"2022","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.isci.2026.115441_bib100","doi-asserted-by":"crossref","first-page":"e00898-17","DOI":"10.1128\/AAC.00898-17","article-title":"Repurposing thiram and disulfiram as antibacterial agents for multidrug-resistant staphylococcus aureus infections","volume":"61","author":"Long","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2026.115441_bib101","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3390\/antibiotics9090633","article-title":"Repurposing disulfiram (tetraethylthiuram disulfide) as a potential drug candidate against Borrelia burgdorferi in vitro and in vivo","volume":"9","author":"Potula","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.isci.2026.115441_bib102","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-00078-3","article-title":"Disulfiram induces redox imbalance and perturbations in central glucose catabolism and metal homeostasis to inhibit the growth of Staphylococcus aureus","volume":"15","author":"Long","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115441_bib103","doi-asserted-by":"crossref","first-page":"e01674-17","DOI":"10.1128\/AAC.01674-17","article-title":"A drug repositioning approach reveals that Streptococcus mutans is susceptible to a diverse range of established antimicrobials and nonantibiotics","volume":"62","author":"Saputo","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2026.115441_bib104","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.molcel.2019.04.001","article-title":"Metabolomics-driven exploration of the chemical drug space to predict combination antimicrobial therapies","volume":"74","author":"Campos","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.115441_bib105","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/jac\/dkz018","article-title":"Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria","volume":"74","author":"Das","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.isci.2026.115441_bib106","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijantimicag.2019.03.024","article-title":"Repurposing disulfiram for treatment of Staphylococcus aureus infections","volume":"53","author":"Thakare","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.isci.2026.115441_bib107","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3390\/antibiotics11121752","article-title":"Repurposing disulfiram as an antimicrobial agent in topical infections","volume":"11","author":"Lajarin-Reinares","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.isci.2026.115441_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1455696","article-title":"Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of Clostridium botulinum and Bacillus anthracis","volume":"15","author":"Borho","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2026.115441_bib109","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100465RR","article-title":"High-throughput tandem-microwell assay for ammonia repositions FDA-Approved drugs to inhibit Helicobacter pylori urease","volume":"35","author":"Liu","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2026.115441_bib110","doi-asserted-by":"crossref","first-page":"e00609-19","DOI":"10.1128\/AAC.00609-19","article-title":"The repurposed drug disulfiram inhibits urease and aldehyde dehydrogenase and prevents in vitro growth of the oomycete pythium insidiosum","volume":"63","author":"Krajaejun","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2026.115441_bib111","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12941-015-0090-4","article-title":"Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans","volume":"14","author":"Kim","year":"2015","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.isci.2026.115441_bib112","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3390\/pharmaceutics15051436","article-title":"Repurposing disulfiram as an antifungal agent: development of a new disulfiram vaginal mucoadhesive gel","volume":"15","author":"Lajarin-Reinares","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.isci.2026.115441_bib113","article-title":"Antifungal activity of the repurposed drug disulfiram against Cryptococcus neoformans","volume":"14","author":"Peng","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2026.115441_bib114","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijpddr.2017.11.003","article-title":"Disulfiram as a novel inactivator of Giardia lamblia triosephosphate isomerase with antigiardial potential","volume":"7","author":"Castillo-Villanueva","year":"2017","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.isci.2026.115441_bib115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/14756366.2018.1540474","article-title":"Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening","volume":"34","author":"Sarwono","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.isci.2026.115441_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115179","article-title":"Identification and characterisation of the tegument-expressed aldehyde dehydrogenase SmALDH_312 of Schistosoma mansoni, a target of disulfiram","volume":"251","author":"Beutler","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.isci.2026.115441_bib117","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","article-title":"FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation","volume":"21","author":"Hu","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.isci.2026.115441_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108545","article-title":"Disulfiram inhibits oxidative stress and NLRP3 inflammasome activation to prevent LPS-induced cardiac injury","volume":"105","author":"Wei","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2026.115441_bib119","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1021\/acschembio.2c00445","article-title":"A class of disulfide compounds suppresses ferroptosis by stabilizing GPX4","volume":"17","author":"Liu","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.isci.2026.115441_bib120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4196\/kjpp.2023.27.5.471","article-title":"Dendritic cells resist to disulfiram-induced cytotoxicity, but reduced interleukin-12\/23(p40) production","volume":"27","author":"Jung","year":"2023","journal-title":"KOREAN J. PHYSIOL. PHARMACOL."},{"key":"10.1016\/j.isci.2026.115441_bib121","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71770-z","article-title":"Antifibrotic effect of disulfiram on bleomycin-induced lung fibrosis in mice and its impact on macrophage infiltration","volume":"14","author":"Okabe","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115441_bib122","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s10735-025-10613-1","article-title":"Repurposing disulfiram: targeting Zeb1 to attenuate paraquat-induced pulmonary fibrosis in rats","volume":"56","author":"Karimzadeh","year":"2025","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.isci.2026.115441_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2025.103588","article-title":"Disulfiram activation of prostaglandin E2 synthesis: a novel antifibrotic mechanism in pulmonary fibrosis","volume":"392","author":"Pei","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.isci.2026.115441_bib124","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41514-020-0046-6","article-title":"Elucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome","volume":"6","author":"Bernier","year":"2020","journal-title":"NPJ Aging Mech. Dis."},{"key":"10.1016\/j.isci.2026.115441_bib125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cmet.2020.04.019","article-title":"Disulfiram treatment normalizes body weight in obese mice","volume":"32","author":"Bernier","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2026.115441_bib126","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2147\/DMSO.S254267","article-title":"Repurposing disulfiram as an anti-obesity drug: treating and preventing obesity in high-fat-fed rats","volume":"13","author":"Omran","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.isci.2026.115441_bib127","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/hmg\/ddaf061","article-title":"The copper ionophore disulfiram improves mitochondrial function in various yeast and human cellular models of mitochondrial diseases","volume":"34","author":"Almyre","year":"2025","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.isci.2026.115441_bib128","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.3390\/ijms22084057","article-title":"Disulfiram abrogates morphine tolerance\u2014a possible role of \u03bc-opioid receptor-related g-protein activation in the striatum","volume":"22","author":"de Cord\u00e9-Skurska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.115441_bib129","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0014-2999(77)90046-2","article-title":"Disulfiram inhibition of development of tolerance to analgesia induced by central gray stimulation in humans","volume":"43","author":"Hosobuchi","year":"1977","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.isci.2026.115441_bib130","article-title":"Scale-up and quality control challenges in the industrial manufacturing of nanoformulations: Current trends and future perspectives","volume":"16","author":"Sammasagi","year":"2025","journal-title":"Int. J. Environ. Sci. Technol."},{"key":"10.1016\/j.isci.2026.115441_bib131","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.nano.2016.08.001","article-title":"Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cells","volume":"13","author":"Wang","year":"2017","journal-title":"Nanomedicine."},{"key":"10.1016\/j.isci.2026.115441_bib132","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.18632\/oncotarget.23320","article-title":"Brain- and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts","volume":"9","author":"Madala","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.115441_bib133","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijpharm.2018.12.051","article-title":"Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors","volume":"557","author":"Banerjee","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2026.115441_bib134","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41416-019-0609-0","article-title":"Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies","volume":"121","author":"Kita","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.115441_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.112690","article-title":"Denatured food protein-coated nanosuspension: A promising approach for anticancer delivery of hydrophobic drug","volume":"303","author":"Farooq","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.isci.2026.115441_bib136","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12951-019-0565-0","article-title":"Soybean lecithin stabilizes disulfiram nanosuspensions with a high drug-loading content: Remarkably improved antitumor efficacy","volume":"18","author":"Li","year":"2020","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.isci.2026.115441_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcou.2020.101187","article-title":"Sub-micronization of disulfiram and disulfiram-copper complexes by Rapid expansion of supercritical solution toward augmented anticancer effect","volume":"39","author":"Tang","year":"2020","journal-title":"J. CO2 Util."},{"key":"10.1016\/j.isci.2026.115441_bib138","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3390\/pharmaceutics13091348","article-title":"Plate-like alginate microparticles with disulfiram-SPIO-coencapsulation: an in vivo study for combined therapy on ovarian cancer","volume":"13","author":"Bai","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.isci.2026.115441_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213038","article-title":"Folic acid-modified disulfiram\/Zn-IRMOF3 nanoparticles for oral cancer therapy by inhibiting ALDH1A1+ cancer stem cells","volume":"139","author":"Cui","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.isci.2026.115441_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121880","article-title":"Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy","volume":"291","author":"Li","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.isci.2026.115441_bib141","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jcis.2022.01.187","article-title":"Disulfiram-loaded metal organicframework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation","volume":"615","author":"Zhang","year":"2022","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.isci.2026.115441_bib142","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1021\/acs.langmuir.1c03256","article-title":"Smart tumor microenvironment-responsive nano-prodrug for disulfiram toxification in situ and the exploration of lethal mechanisms in cells","volume":"38","author":"Zhang","year":"2022","journal-title":"Langmuir"},{"key":"10.1016\/j.isci.2026.115441_bib143","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/03639045.2023.2216785","article-title":"Concurrent oral delivery of non-oncology drugs through solid self-emulsifying system for repurposing in hepatocellular carcinoma","volume":"49","author":"Ardad","year":"2023","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.isci.2026.115441_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124187","article-title":"Cyclodextrin encapsulation enabling the anticancer repositioning of disulfiram: Preparation, analytical and in vitro biological characterization of the inclusion complexes","volume":"657","author":"Benk\u0151","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2026.115441_bib145","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12951-024-02492-7","article-title":"LIFU\/MMP-2 dual-responsive release of repurposed drug disulfiram from nanodroplets for inhibiting vasculogenic mimicry and lung metastasis in triple-negative breast cancer","volume":"22","author":"Liu","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.isci.2026.115441_bib146","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/20415990.2024.2363136","article-title":"Quality-by-design-based microemulsion of disulfiram for repurposing in melanoma and breast cancer therapy","volume":"15","author":"Mohapatra","year":"2024","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.isci.2026.115441_bib147","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.12991\/jrespharm.1734556","article-title":"Oral solid self-emulsifying system containing non-oncology drug combination for repurposing in melanoma treatment: In vitro cytotoxicity, and in vivo hematotoxicity and pharmacokinetic study","volume":"29","author":"Ardad","year":"2025","journal-title":"J. Res. Pharm."},{"key":"10.1016\/j.isci.2026.115441_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113615","article-title":"Disulfiram-loaded electrospun fibers with antimicrobial and antitumoral properties for glioblastoma treatment","volume":"381","author":"Gonzalez-Prada","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.isci.2026.115441_bib149","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/pharmaceutics17070849","article-title":"Development of low-dose disulfiram rectal suppository intended for application in post-treatment Lyme disease syndrome","volume":"17","author":"Benk\u0151","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.isci.2026.115441_bib150","article-title":"Microenvironment-responsive Cu-MOF nanoplatform activates disulfiram for synergistic bacterial killing and enhanced infected wound healing","volume":"15","author":"Liu","year":"2026","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.isci.2026.115441_bib151","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s41401-021-00770-w","article-title":"Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases","volume":"42","author":"Ou","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.isci.2026.115441_bib152","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1021\/acs.molpharmaceut.3c00462","article-title":"Microgel encapsulated nanoparticles for intra-articular disulfiram delivery to treat osteoarthritis","volume":"21","author":"Liu","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.isci.2026.115441_bib153","doi-asserted-by":"crossref","first-page":"12244","DOI":"10.1021\/acsami.3c17659","article-title":"Repurposing disulfiram to combat acute respiratory distress syndrome with targeted delivery by LET-functionalized nanoplatforms","volume":"16","author":"Tian","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.isci.2026.115441_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120807","article-title":"PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up","volume":"605","author":"Operti","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.isci.2026.115441_bib155","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3390\/pharmaceutics17121613","article-title":"PLGA-based co-delivery nanoformulations: overview, strategies, and recent advances","volume":"17","author":"Stevanovi\u0107","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.isci.2026.115441_bib156","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.drudis.2022.06.001","article-title":"Multiple deadlocks in the development of nonprofit drugs","volume":"27","author":"Cvek","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.isci.2026.115441_bib157","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1021\/acsmedchemlett.3c00450","article-title":"The Promiscuity of Disulfiram in Medicinal Research","volume":"14","author":"Cvek","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.isci.2026.115441_bib158","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2147\/TCRM.S40232","article-title":"Ethical and legal framework and regulation for off-label use: European perspective","volume":"10","author":"Lenk","year":"2014","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.isci.2026.115441_bib159","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph181910447","article-title":"Off-label medication: from a simple concept to complex practical aspects","volume":"18","author":"Rusz","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.isci.2026.115441_bib160","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.clinthera.2012.09.004","article-title":"Japanese regulatory system for approval of off-label drug use: evaluation of safety and effectiveness in literature-based applications","volume":"34","author":"Shimazawa","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.isci.2026.115441_bib161","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226008163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226008163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:15:56Z","timestamp":1781831756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226008163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":161,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2589004226008163"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115441","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115441"}}